Current and emerging pharmacotherapies for obesity in Australia

This publication has 40 references indexed in Scilit:

• Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
  The Lancet, 2016
• The Relationship between Body Mass Index and Hospitalisation Rates, Days in Hospital and Costs: Findings from a Large Prospective Linked Data Study
  PLOS ONE, 2015
• The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
  Journal of Clinical Investigation, 2014
• Serotonin 5-HT_2C receptor-mediated inhibition of the M-current in hypothalamic POMC neurons
  American Journal of Physiology-Endocrinology and Metabolism, 2012
• Long-Term Persistence of Hormonal Adaptations to Weight Loss
  New England Journal of Medicine, 2011
• Future predictions of body mass index and overweight prevalence in Australia, 2005-2025
  Health Promotion International, 2011
• Pharmacotherapies for Obesity: Past, Current, and Future Therapies
  Journal of Obesity, 2010
• The Medical Risks of Obesity
  Postgraduate Medicine, 2009
• Long-term weight loss after diet and exercise: a systematic review
  International Journal of Obesity, 2005
• Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
  New England Journal of Medicine, 2002